EYPT
EyePoint Pharmaceuticals (EYPT)
$83
About EyePoint Pharmaceuticals (EYPT)
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Details
Daily high
$7.58
Daily low
$6.78
Price at open
$7.36
52 Week High
$23.97
52 Week Low
$5.54
Market cap
503.8M
Dividend yield
0.00%
Volume
713,412
Avg. volume
789,053
P/E ratio
-3.17
EyePoint Pharmaceuticals News
Details
Daily high
$7.58
Daily low
$6.78
Price at open
$7.36
52 Week High
$23.97
52 Week Low
$5.54
Market cap
503.8M
Dividend yield
0.00%
Volume
713,412
Avg. volume
789,053
P/E ratio
-3.17